1. Home
  2. Labeler Index
  3. Patheon Manufacturing Services Llc
  4. 63552-114
  5. NDC Package Code: 63552-114-00 Bevacizumab

NDC Package 63552-114-00 Bevacizumab

Injection, Solution - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
63552-114-00
Package Description:
80 VIAL in 1 CASE / 16 mL in 1 VIAL
Product Code:
63552-114
Non-Proprietary Name:
Bevacizumab
Substance Name:
Bevacizumab
Usage Information:
This medication is a man-made antibody (IgG1) used to treat various types of cancer. This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, and bevacizumab-bvzr.
11-Digit NDC Billing Format:
63552011400
Product Type:
Drug For Further Processing
Labeler Name:
Patheon Manufacturing Services Llc
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Active Ingredient(s):
  • BEVACIZUMAB 400 mg/16mL
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    02-26-2004
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 63552-114-00?

    The NDC Packaged Code 63552-114-00 is assigned to an UNFINISHED drug package of 80 vial in 1 case / 16 ml in 1 vial of Bevacizumab, drug for further processing labeled by Patheon Manufacturing Services Llc. The product's dosage form is injection, solution and is administered via form.

    Is NDC 63552-114 included in the NDC Directory?

    Yes, Bevacizumab is an UNFINISHED PRODUCT with code 63552-114 that is active and included in the NDC Directory. The product was first marketed by Patheon Manufacturing Services Llc on February 26, 2004 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 63552-114-00?

    The 11-digit format is 63552011400. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-263552-114-005-4-263552-0114-00